10 April, 2024, Prague, Czech Republic—The same technology that enables a bullet train to travel at speeds up to 200 mph without touching its rails now keeps a failing heart pumping—and in the near ...
The same technology that enables a bullet train to travel at speeds up to 200 mph without touching its rails now keeps a failing heart pumping - and in the near future, it will do so via a wireless ...
HOUSTON--(BUSINESS WIRE)--Saranas, Inc. announced today that it has completed enrollment in SAFE-MCS, a multi-center, single arm, open-label clinical trial evaluating the safety of complex high-risk ...
At today's Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT) in Boston, Angela Lorts, MD, MBA, issued an urgent call for improved ...
CHICAGO, IL USA – 5 February, 2025 – Following a five-year hiatus, the world’s only registry of patients with durable mechanical circulatory support (MCS) devices is re-launching and will begin ...
HOUSTON--(BUSINESS WIRE)--Saranas, Inc. announced today the compelling results of SAFE-MCS, a multi-center clinical study evaluating the safety of complex high-risk percutaneous coronary intervention ...
Magenta Medical wants to disrupt the mechanical circulatory support (MCS) market with the Elevate Percutaneous Left Ventricular Assist Device (pLVAD). The Kadima, Israel-based company is developing ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock Receive the the latest news, research, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback